Antifibrinolytics in liver transplantation.
Groenland
Theo H N
TH
Department of Anesthesiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Porte
Robert J
RJ
D015119:Aminocaproic Acid / Q000009:adverse effects / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D007611:Aprotinin / Q000009:adverse effects / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D006801:Humans; D016031:Liver Transplantation; D013923:Thromboembolism / Q000139:chemically induced; D014148:Tranexamic Acid / Q000009:adverse effects / Q000627:therapeutic use
D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid; D007611:Aprotinin; D015119:Aminocaproic Acid